Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats

被引:201
作者
Hsu, FL
Liu, IM
Kuo, DH
Chen, WC
Su, HC
Cheng, JT [1 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan
[2] Taipei Med Univ, Sch Pharm, Inst Pharmacognosy, Taipei 11031, Taiwan
[3] Jin Ai Municipal Hosp, Dept Chinese Med, Taipei 10501, Taiwan
[4] Tajen Inst Technol, Dept Pharm, Yen Pou 90701, Ping Tung Shien, Taiwan
来源
JOURNAL OF NATURAL PRODUCTS | 2003年 / 66卷 / 06期
关键词
D O I
10.1021/np0203887
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The antihyperglycemic action of puerarin, purified from the roots of Pueraria lobata, was investigated in streptozotocin-induced diabetic rats (STZ-diabetic rats). Bolus intravenous injection of puerarin decreased the plasma glucose concentrations in a dose-dependent manner in STZ-diabetic rats. Similar treatment with puerarin also decreased the plasma glucose in normal rats, although the effect was not as great as that in STZ-diabetic rats. Puerarin at the effective dose (15.0 mg/kg) significantly attenuated the increase of plasma glucose induced by an intravenous glucose challenge test in normal rats. In the isolated soleus muscle of STZ-diabetic rats, puerarin enhanced the uptake of radioactive glucose in a concentration-dependent manner. Moreover, the mRNA and protein levels of the subtype 4 form of glucose transporter (GLUT4) in soleus muscle were increased after repeated intravenous administration of puerarin in STZ-diabetic rats for 3 days. These results suggest that puerarin can increase the glucose utilization to lower plasma glucose in diabetic rats lacking insulin.
引用
收藏
页码:788 / 792
页数:5
相关论文
共 18 条
[1]   RATES AND TISSUE SITES OF NON-INSULIN-MEDIATED AND INSULIN-MEDIATED GLUCOSE-UPTAKE IN HUMANS [J].
BARON, AD ;
BRECHTEL, G ;
WALLACE, P ;
EDELMAN, SV .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 255 (06) :E769-E774
[2]   DECREASED EXPRESSION OF THE INSULIN-RESPONSIVE GLUCOSE TRANSPORTER IN DIABETES AND FASTING [J].
BERGER, J ;
BISWAS, C ;
VICARIO, PP ;
STROUT, HV ;
SAPERSTEIN, R ;
PILCH, PF .
NATURE, 1989, 340 (6228) :70-72
[3]   Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats [J].
Cheng, JT ;
Liu, IM ;
Chi, TC ;
Tzeng, TF ;
Lu, FH ;
Chang, CJ .
DIABETES, 2001, 50 (12) :2815-2821
[4]  
FAN LL, 1984, ACTA PHARMACOL SINIC, V19, P801
[5]   DIABETIC NEPHROPATHY - CLINICAL COURSE AND EFFECT OF HEMODIALYSIS [J].
GOLDSTEIN, DA ;
MASSRY, SG .
NEPHRON, 1978, 20 (05) :286-296
[6]   GLUCOSE TRANSPORTER NUMBER, ACTIVITY, AND ISOFORM CONTENT IN PLASMA-MEMBRANES OF RED AND WHITE SKELETAL-MUSCLE [J].
GOODYEAR, LJ ;
HIRSHMAN, MF ;
SMITH, RJ ;
HORTON, ES .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (05) :E556-E561
[7]   GLUCOSE TRANSPORTER PROTEIN-CONTENT AND GLUCOSE-TRANSPORT CAPACITY IN RAT SKELETAL-MUSCLES [J].
HENRIKSEN, EJ ;
BOUREY, RE ;
RODNICK, KJ ;
KORANYI, L ;
PERMUTT, MA ;
HOLLOSZY, JO .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (04) :E593-E598
[8]   VARIATIONS IN INSULIN-STIMULATED GLUCOSE-UPTAKE IN HEALTHY-INDIVIDUALS WITH NORMAL GLUCOSE-TOLERANCE [J].
HOLLENBECK, C ;
REAVEN, GM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 64 (06) :1169-1173
[9]  
Kaufman P B, 1997, J Altern Complement Med, V3, P7, DOI 10.1089/acm.1997.3.7
[10]  
Kim DH, 1998, BIOL PHARM BULL, V21, P628, DOI 10.1248/bpb.21.628